Pediatrix Medical Group, Inc.
Financials
Valuation Metrics
Pediatrix Medical Group, Inc.'s Market Cap is $2.13B. At end of 2025 it was $1.81B. Ranked #1993 of 3,121 in US market (top 64%), #1237 of 1,658 on NYSE (top 75%), #119 of 205 in Health Care Equipment & Services (top 58%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.13B | US#1,993/3,121 Sec#119/205 |
| Revenue | $1.95B | US#1,456/3,121 Sec#91/205 |
| Net Income | $175M | US#1,359/3,121 Sec#65/205 |
| Total Assets | $2.13B | US#2,044/3,121 Sec#100/205 |
| Net Assets | $881M | US#1,860/3,121 Sec#97/205 |
| Employees | 4,280 | US#1,314/3,121 Sec#93/205 |
| Value | ||
| P/E | 12.18x | US#518/3,121 Sec#9/205 |
| P/B | 2.42x | US#1,473/3,121 Sec#74/205 |
| PEG | 0.21x | US#333/3,121 Sec#12/205 |
| P/S | 1.09x | US#742/3,121 Sec#52/205 |
| EV/EBITDA | 9.21x | US#664/3,121 Sec#22/205 |
| FCF Yield | 10.75% | US#495/3,121 Sec#19/205 |
| Profitability | ||
| ROE | 19.84% | US#591/3,121 Sec#28/205 |
| ROA | 8.21% | US#633/3,121 Sec#36/205 |
| Op. Margin | 11.60% | US#1,468/3,121 Sec#64/205 |
| Revenue Growth | 0.51% | US#2,220/3,121 Sec#163/205 |
| Earnings Growth | 59.03% | US#454/3,121 Sec#20/205 |
| Financial Health | ||
| Debt Ratio | 141.82% | US#1,440/3,121 Sec#132/205 |
| Total Debt | $620M | US#1,772/3,121 Sec#97/205 |
| FCF | $229M | US#1,315/3,121 Sec#75/205 |
| Cash | $289M | US#1,449/3,121 Sec#83/205 |
| Current Ratio | 1.32x | US#1,875/3,121 Sec#162/205 |
| Net Debt/EBITDA | 1.24x | US#1,063/3,121 Sec#62/205 |
| Performance | ||
| 1Y Return | 56.30% | US#483/3,121 Sec#45/205 |
| 1M Return | -1.11% | US#1,545/3,121 Sec#126/205 |
| From 52W High | -7.19% | US#605/3,121 Sec#59/205 |
| 1Y MDD | -23.65% | US#968/3,121 Sec#27/205 |
| Trading | ||
| Volume | 544,353 shares | US#2,152/3,121 Sec#154/205 |
| Trading Value | $14M | US#2,291/3,121 Sec#154/205 |
| Per Share | ||
| EPS | $2.13 | US#1,296/3,121 Sec#65/205 |
| BPS | $10.73 | US#1,799/3,121 Sec#100/205 |
Company Info
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.